Cargando…

Evaluating the Clinical and Economic Outcomes Associated with Poor Glycemic Control in People with Type 1 Diabetes in the Netherlands

INTRODUCTION: Achieving and maintaining glycemic control is the cornerstone of type 1 diabetes management, with the aim of reducing the incidence of diabetes-related complications over the long term. However, many individuals fail to reach glycemic targets. The present study evaluated the clinical a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moes, Robert Gerald Jan, Huisman, Eline L, Malkin, Samuel J P, Hunt, Barnaby
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910197/ https://www.ncbi.nlm.nih.gov/pubmed/36778040 http://dx.doi.org/10.2147/CEOR.S391626

Ejemplares similares

Once-weekly semaglutide for patients with type 2 diabetes: a cost-effectiveness analysis in the Netherlands
por: Hunt, Barnaby, et al.
Publicado: (2019)

Modeling the Long-Term Cost-Effectiveness of IDegLira in Patients with Type 2 Diabetes Who are Failing To Meet Glycemic Targets on Basal Insulin Alone in The Netherlands
por: Hunt, Barnaby, et al.
Publicado: (2017)

The burden of poor glycaemic control in people with newly diagnosed type 2 diabetes in Sweden: A health economic modelling analysis based on nationwide data
por: Hellgren, Margareta, et al.
Publicado: (2021)

Evaluation of the long‐term cost‐effectiveness of once‐weekly semaglutide versus dulaglutide for treatment of type 2 diabetes mellitus in the UK
por: Viljoen, Adie, et al.
Publicado: (2018)

The Management of Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide: A Long-Term Cost-Effectiveness Analysis in Slovakia
por: Malkin, Samuel J. P., et al.
Publicado: (2019)

Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide 1 mg Versus Liraglutide 1.8 mg: A Health Economic Analysis in the UK
por: Evans, Marc, et al.
Publicado: (2023)

Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes: A Long-Term Cost-Effectiveness Analysis in Estonia
por: Malkin, Samuel J. P., et al.
Publicado: (2018)

Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes in the UK
por: Johansen, Pierre, et al.
Publicado: (2020)

Once‐weekly semaglutide versus insulin aspart for the treatment of type 2 diabetes in the UK: A long‐term cost‐effectiveness analysis based on SUSTAIN 11
por: Evans, Marc, et al.
Publicado: (2022)

The management of type 2 diabetes with fixed‐ratio combination insulin degludec/liraglutide (IDegLira) versus basal‐bolus therapy (insulin glargine U100 plus insulin aspart): A short‐term cost‐effectiveness analysis in the UK setting
por: Drummond, Russell, et al.
Publicado: (2018)

Achieving Good Glycemic Control Early After Onset of Diabetes: A Cost-Effectiveness Analysis in Patients with Type 1 Diabetes in Sweden
por: Jendle, Johan, et al.
Publicado: (2017)

The Short-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin and Once-Weekly Dulaglutide for the Treatment of Patients with Type 2 Diabetes: A Cost of Control Analysis in Spain
por: Vidal, Josep, et al.
Publicado: (2020)

Management of Patients with Type 2 Diabetes with Once-Weekly Semaglutide Versus Dulaglutide, Exenatide ER, Liraglutide and Lixisenatide: A Cost-Effectiveness Analysis in the Danish Setting
por: Gæde, Peter, et al.
Publicado: (2019)

Prevalence, associations and health outcomes of binge eating in adults with type 1 or type 2 diabetes: Results from Diabetes MILES – The Netherlands
por: Huisman, Sasja D., et al.
Publicado: (2022)

Evaluation of the Clinical and Economic Burden of Poor Glycemic Control Associated with Therapeutic Inertia in Patients with Type 2 Diabetes in the United States
por: Ali, Sarah Naz, et al.
Publicado: (2020)

Real-World Data in Support of Short Sleep Duration with Poor Glycemic Control, in People with Type 2 Diabetes Mellitus
por: Martorina, Wagner, et al.
Publicado: (2019)

Hypertension, poor glycemic control, and microalbuminuria in Cuban Americans with type 2 diabetes
por: Zarini, Gustavo G, et al.
Publicado: (2011)

Impacts of the COVID-19 pandemic on unmet social needs, self-care, and outcomes among people with diabetes and poor glycemic control
por: Patel, Minal R., et al.
Publicado: (2022)

The Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes: a Health Economic Analysis in Sweden
por: Jendle, Johan, et al.
Publicado: (2021)

The Association of Mindful Parenting with Glycemic Control and Quality of Life in Adolescents with Type 1 Diabetes: Results from Diabetes MILES—The Netherlands
por: Serkel-Schrama, Inge J. P., et al.
Publicado: (2016)

Factors that Correlate with Poor Glycemic Control in Type 2 Diabetes Mellitus Patients with Complications
por: Haghighatpanah, Mohammad, et al.
Publicado: (2018)

Predictors of poor glycemic control in adult with type 2 diabetes in South-Eastern Nigeria
por: Anioke, Innocent Chidi, et al.
Publicado: (2019)

Glycemic outcomes of people with diabetes mellitus in Brazilian primary health care
por: Calixto, Adrielen Aparecida Silva, et al.
Publicado: (2023)

The long-term cost-effectiveness of oral semaglutide versus empagliflozin and dulaglutide in Portugal
por: Malkin, Samuel J. P., et al.
Publicado: (2022)

Early use of oral semaglutide in the UK: A cost-effectiveness analysis versus continuing metformin and SGLT-2 inhibitor therapy
por: Ren, Hongye, et al.
Publicado: (2023)

Risk for developing perianal abscess in type 1 and type 2 diabetes and the impact of poor glycemic control
por: Adamo, Karin, et al.
Publicado: (2020)

Predictors of poor glycemic control and level of glycemic control among diabetic patients in west Ethiopia
por: Dedefo, Mohammed Gebre, et al.
Publicado: (2020)

Serum Metabolomics Reveals a Potential Benefit of Methionine in Type 1 Diabetes Patients with Poor Glycemic Control and High Glycemic Variability
por: Zhang, Liyin, et al.
Publicado: (2023)

Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands: Clinical and Economic Effects
por: de Jong, Lisa A., et al.
Publicado: (2018)

Socioeconomic Factors Associated With Glycemic Measurement and Poor HbA1c Control in People With Type 2 Diabetes: The Global DISCOVER Study
por: Gomes, Marília B., et al.
Publicado: (2022)

Effect of COVID 19 Lockdown on glycemic parameters in people with type 2 diabetes
por: Tewari, Ajoy, et al.
Publicado: (2021)

Comparison of endothelial progenitor cell function in type 2 diabetes with good and poor glycemic control
por: Churdchomjan, Worachat, et al.
Publicado: (2010)

Poor glycemic control is associated with the risk of subclinical hypothyroidism in patients with type 2 diabetes mellitus
por: Cho, Jae Ho, et al.
Publicado: (2016)

Depressive symptoms are associated with poor glycemic control among women with type 2 diabetes mellitus
por: Góis, Carlos, et al.
Publicado: (2018)

The impact of poor glycemic control on lipid profile variables in children with type 1 diabetes mellitus
por: Mostofizadeh, Neda, et al.
Publicado: (2019)

Evaluation of the Short-Term Cost-Effectiveness of IDegLira Versus Basal Insulin and Basal-Bolus Therapy in Patients with Type 2 Diabetes Based on Attainment of Clinically Relevant Treatment Targets
por: Cannon, Anthony J., et al.
Publicado: (2020)

Identifying older diabetic patients at risk of poor glycemic control
por: Incalzi, Raffaele Antonelli, et al.
Publicado: (2002)

Increased stress, weight gain and less exercise in relation to glycemic control in people with type 1 and type 2 diabetes during the COVID-19 pandemic
por: Ruissen, Merel M, et al.
Publicado: (2021)

Machine Learning Approaches to Predict Risks of Diabetic Complications and Poor Glycemic Control in Nonadherent Type 2 Diabetes
por: Fan, Yuting, et al.
Publicado: (2021)

Adiposity contributes to poor glycemic control in people with diabetes mellitus, a randomized case study, in South Kashmir, India
por: Wagai, Gowher Ahmad, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ff0dm8cp6grg9gjlab9s6mj3j4